Bookmark and Share

News & Events

University of Maryland School of Medicine Appoints New Senior Associate Dean for Clinical Affairs

Thursday, January 05, 2012

Lehman_Tony_2008.jpg
 Anthony F. Lehman, MD, MSPH, is the new senior associate dean for clinical affairs.
 

University of Maryland School of Medicine Dean E. Albert Reece, M.D., Ph.D., M.B.A., has appointed Anthony F. Lehman, M.D., M.S.P.H., as the new senior associate dean for clinical affairs.

In his new role, Dr. Lehman — professor and chair of the Department of Psychiatry — will work closely with the University of Maryland Medical Center, the University of Maryland Medical System, the Baltimore VA Medical Center and the medical school’s faculty practice plan to strengthen the School of Medicine’s clinical affairs efforts. Initially, he will continue serving as professor and chair of psychiatry, pending a national search for a new psychiatry chair.

“Clinical affairs are a crucial component of our mission here at the University of Maryland — to provide world class patient care in addition to conducting groundbreaking research and providing outstanding education,” says Dean Reece, who also is vice president for medical affairs at the University of Maryland and John Z. and Akiko K. Bowers Distinguished Professor at the School of Medicine. “Dr. Lehman will lead the School of Medicine’s clinical initiatives, developing strategies for our clinical mission for both inpatient and outpatient services. He will explore new program developments and work to create new initiatives to enhance the School of Medicine’s clinical affairs effort. He will closely collaborate with our partners at the medical center, the medical system and the VA Maryland Medical Center and with our various School of Medicine department chairs to strengthen clinical care within the entire medical enterprise.”

Dr. Lehman replaces Frank M. Calia, M.D., M.A.C.P., who is retiring after 42 years at the University of Maryland School of Medicine. Dr. Calia served most recently as vice dean for clinical affairs, and has served as chair and interim chair of the Department of Medicine at various points in his long and distinguished career at the medical school.

 “We are deeply grateful to Dr. Calia for his many years of loyal service to the School of Medicine,” says Dean Reece. “He is leaving a robust clinical affairs program, and I feel confident that Dr. Lehman is the right choice to continue the program’s growth and expansion and take our clinical work to new heights. Dr. Lehman has proven himself to be a skilled clinician, an exceptionally strong leader and a willing collaborator with our partners. We will begin very soon to search for another outstanding leader to keep our psychiatry program strong and successful, and to allow Dr. Lehman to fully transition into his new role.”

In his new position, Dr. Lehman will also provide leadership to the University of Maryland School of Medicine’s faculty practice plan, University of Maryland Faculty Physicians Inc., in conjunction with Dean Reece, who also serves as president of the practice plan, and William E. Tucker, M.B.A, C.P.A., who is assistant dean for practice plan affairs and the practice plan’s chief corporate officer.

“I am honored and excited about this opportunity to work closely with Dean Reece and the clinical leadership of the School of Medicine to continue to grow our outstanding clinical programs and practices. These programs provide critical services to the citizens of Maryland, the region and beyond and contribute substantially to our educational and research missions. I look forward to working closely with our stellar faculty and our clinical partners at the University of Maryland Medical Center, the University of Maryland Medical System, and the Baltimore VA Medical Center.”

Dr. Lehman’s recent research has focused on improving reimbursement for mental health services and improving the quality of care for people with schizophrenia. He also has studied outcomes of persons with severe and persistent mental illnesses, in particular assessing quality of life. His research has examined the impacts of substance use disorders among persons with mental illnesses on diagnosis and outcomes, the effectiveness of assertive community treatment programs for homeless persons with severe mental disorders, and the effectiveness of interventions for families. He was Principal Investigator for the Schizophrenia Patient Outcomes Research Team, funded by the Agency for Health Care Policy and Research and the National Institute of Mental Health (NIMH). He was also Principal Investigator on the Maryland Employment Demonstration Project for Persons with Psychiatric Disabilities, funded by the Center for Mental Health Services, and Co-Principal Investigator on the NIMH-funded Center for Research on Services for Severe Mental Illnesses and the Maryland Medicaid Patterns of Care and Outcomes Study, also funded by NIMH. Dr. Lehman chaired the American Psychiatric Association work group that wrote the APA Guidelines for the Treatment of Persons with Schizophrenia.

Dr. Lehman earned his B.S. degree from St. Lawrence University (1970) in Canton, N.Y., and then went on to earn his medical degree from the University of Rochester School of Medicine (1975). He continued his training with an internship at the University of Virginia School of Medicine and a residency in psychiatry at the University of California, Los Angeles (UCLA) Neuropsychiatric Institute. He completed a postdoctoral fellowship at the Robert Wood Johnson Clinical Scholar Program at UCLA, and earned his M.S. in public health from the UCLA School of Public Health in 1981.

In 1981, Dr. Lehman began working at the University of Rochester as an assistant professor of psychiatry, director of the Long-Term Care Program and Medical Director of the Extended Care Clinic. He joined the University of Maryland School of Medicine as an associate professor of psychiatry in 1986 and became a professor of psychiatry in 1994. He was named acting chair of the Department of Psychiatry in 1998, and chair in 2000.

The University of Maryland School of Medicine’s Department of Psychiatry has nearly $18 million in external research funding. The department is a major center of excellence in clinical and translational research studying schizophrenia and related illnesses, spanning basic neurobiology to health services and public health research. The department educates medical students and also includes one of the largest and most competitive psychiatry residency programs in the nation. Its faculty members treat patients in communities throughout Maryland, the region and beyond.

Dr. Lehman is a highly regarded psychiatrist and scientist and has received many awards and honors. In 2005, he received the Alexander Gralnick Award for Research in Schizophrenia from the American Psychiatric Association (APA), and in 2003 he was named a distinguished fellow of the APA. In 2004, the American Academy of Child and Adolescent Psychiatry presented him with the Robert Cancro Best Chair Award.

Dr. Lehman has served on many committees at the APA, NIMH, the VA Maryland Health Care System and more. He has been an extraordinarily prolific scholar, having written more than 150 scientific articles and co-authored two books, “Working with Families of the Mentally Ill” and “Double Jeopardy: Chronic Mental Illness and Substance Use Disorders.”

 “Dr. Lehman has been an outstanding clinician, scientist, educator and leader throughout his career, and I am convinced he is the ideal candidate to lead our clinical affairs programs into a bright new future,” says Dean Reece.

Contact

Contact Media Relations
Phone: (410) 328-8919

Search Articles